AAAAAA

   
Results: 1-8 |
Results: 8
Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2
Authors: Yamaguchi, Y Ohta, K Shimizu, K Minami, K Noma, K Hihara, J Toge, T
Citation: Y. Yamaguchi et al., Generation of cytotoxic effector lymphocytes by MLTC using tumor cells genetically modified to secrete interleukin-2, ANTICANC R, 21(1B), 2001, pp. 669-677
Significance of Lymph node dissection of the superior mediastinal region in esophageal cancer patients
Authors: Hirai, T Hihara, J Inoue, M Nishimoto, N Kagawa, Y Yoshida, K Toge, T
Citation: T. Hirai et al., Significance of Lymph node dissection of the superior mediastinal region in esophageal cancer patients, DIS ESOPHAG, 13(3), 2000, pp. 198-202
Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM
Authors: Yamaguchi, Y Takashima, I Hihara, J Ohta, K Shimizu, K Minami, K Yoshida, K Toge, T
Citation: Y. Yamaguchi et al., Co-transduction of herpes simplex virus thymidine kinase gene and human interleukin-2 gene into mouse ovarian cancer cell line, OVHM, INT J MOL M, 6(2), 2000, pp. 185-190
p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer
Authors: Kuwahara, M Hirai, T Yoshida, K Yamashita, Y Hihara, J Inoue, H Toge, T
Citation: M. Kuwahara et al., p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancer, DIS ESOPHAG, 12(2), 1999, pp. 116-119
Poor prognosis in esophageal cancer patients with post-operative complications: surgical oncotaxis
Authors: Hihara, J Hirai, T Yamashita, Y Yoshida, K Kuwahara, M Kagawa, Y Toge, T
Citation: J. Hihara et al., Poor prognosis in esophageal cancer patients with post-operative complications: surgical oncotaxis, DIS ESOPHAG, 12(2), 1999, pp. 152-154
Immunological properties of tumor cells genetically modified to secrete interleukin 2
Authors: Takashima, I Yamaguchi, Y Yorishima, T Ohta, K Minami, K Hihara, J Toge, T
Citation: I. Takashima et al., Immunological properties of tumor cells genetically modified to secrete interleukin 2, ANTICANC R, 19(6B), 1999, pp. 5299-5306
T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients
Authors: Miyahara, E Yamaguchi, Y Minami, K Hihara, J Noma, K Toge, T Takafuta, T Fujimura, K
Citation: E. Miyahara et al., T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients, ANTICANC R, 19(3A), 1999, pp. 2057-2066
Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion
Authors: Hihara, J Yamaguchi, Y Minami, K Noma, K Toge, T
Citation: J. Hihara et al., Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion, ANTICANC R, 19(2A), 1999, pp. 1077-1084
Risultati: 1-8 |